Table 1.
Characteristics of the AdICONA Participants and of the Participants Eligible for This Analysis (N = 320)
| Patient-related characteristics | |
| Gender, n (%) | |
| Male | 227 (71) |
| Female | 93 (29) |
| Mean age, y (range) | 36.4 (19 to 66) |
| <35, n (%) | 153 (48) |
| HIV transmission mode, n (%) | |
| Injection drug use | 116 (36) |
| Men having sex with men | 71 (23) |
| Heterosexual intercourse | 116 (36) |
| Receipt of blood products | 14 (4) |
| Unknown | 3 (1) |
| Level of highest education, n (%) | |
| ≤8 years | 148 (46) |
| 9 to 13 years | 117 (37) |
| University | 33 (10) |
| Unknown | 22 (7) |
| Income/month, n (%) | |
| <$350/<Euro 388 | 56 (17) |
| $350 to $1250/Euro 388–1293 | 151 (47) |
| >$1250/>Euro 1293 | 50 (16) |
| Unknown | 63 (20) |
| Unemployment, n (%) | 67 (21) |
| Unknown | 46 (14) |
| Homelessness, n (%) | 8 (2.5) |
| Self-reported alcohol use | 42 (13) |
| Self-reported recreational drugs use | 24 (7.5) |
| HIV-related variables | |
| Previous AIDS-related event, n (%) | 64 (20) |
| HIV RNA copies/ml, median (IQR) | 99 (80 to 562) |
| <500 copies/ml, n (%) | 206 (64) |
| Mean CD4+ cell count × 106/L (SD) | 576 (345) |
| <200, n (%) | 36 (11) |
| Treatment-related variables | |
| Years on antiretroviral therapy | |
| Overall, mean (SD) | 1.6 (0.64) |
| On last HAART scheme, mean (SD) | 1.0 (0.68) |
IQR, interquartile range; SD, standard deviation, HAART, highly active antiretroviral therapy.